deltatrials
Terminated PHASE4 INTERVENTIONAL 4-arm NCT03231397

Predictors of AAA Expansion and/or Rupture

Noninvasive Assessment of Abdominal Aortic Aneurysm (AAA) Wall Structural Integrity and Inflammation as Predictors of Expansion and/or Rupture

Sponsor: Washington University School of Medicine

Conditions Abdominal Aortic Aneurysm (AAA)
Interventions 11C-PBR28 18F-fludeoxyglucose (FDG) Assess AAA rupture risk by PET-CTA scans
Updated 13 times since 2017 Last updated: Jun 17, 2021 Started: Aug 1, 2017 Primary completion: Apr 30, 2020 Completion: Apr 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

We were unable to recruit more subjects who met the inclusion/exclusion criteria and we have closed the study.

Other terminated trials from Washington University School of Medicine

See all terminations from Washington University School of Medicine

Other Abdominal Aortic Aneurysm (AAA) trials with similar outcome

Browse all Abdominal Aortic Aneurysm (AAA) trials

A PHASE4 clinical study on Abdominal Aortic Aneurysm (AAA), this trial is terminated or withdrawn. The trial is conducted by Washington University School of Medicine and has accumulated 13 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Dec 2019 · 13 months · monthly snapshot~Dec 2019 – ~Jun 2020 · 6 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  4. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE4

  5. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE4

▶ Show 8 earlier versions

  1. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE4

  2. Sep 2021 — Dec 2021 [monthly]

    Terminated PHASE4

    Status: Completed → Terminated

  3. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE4

  4. Jun 2020 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  5. Dec 2019 — Jun 2020 [monthly]

    Recruiting PHASE4

  6. Nov 2018 — Dec 2019 [monthly]

    Recruiting PHASE4

    Phase: NA → PHASE4

  7. Jun 2018 — Nov 2018 [monthly]

    Recruiting NA

  8. Aug 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Washington University School of Medicine
Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations